Ally Bridge Group »

Definium Therape shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $19M 400k 47.04

More positions owned by Ally Bridge Group

Definium Therapeutics Com Shs Call Option (DFTX)
Abivax Sa Sponsored Ads Call Option (ABVX)
Minerva Neurosciences Com New (NERV)
Promis Neurosciences Com Shs (PMN)
First Tracks Biotherapeutics Ord Shs (TRAX)
Axsome Therapeutics (AXSM)
Assembly Biosciences Com New (ASMB)
Aadi Bioscience (WHWK)
Edgewise Therapeutics (EWTX)
Eliem Therapeutics (CLYM)
Kura Oncology (KURA)
Cytomx Therapeutics (CTMX)
Avalo Therapeutics Sponsored Ads (AVTX)
Palisade Bio (PALI)
Solid Biosciences (SLDB)

View all positions for Ally Bridge Group

Top funds holding Definium Therape

BlackRock
Driehaus Capital Management
Jupiter Topco
venBio Select Advisor
FMR
Geode Capital Management
Henderson Group
Deep Track Capital
Wellington Management Company
State Street Corporation
Octagon Capital Advisors
Citadel Advisors
Commodore Capital
Alliancebernstein
Goldman Sachs Group

View all funds holding Definium Therape